Want to see HK:6622 full AI Analyst Report?
Zhaoke Ophthalmology Ltd. (6622) Stock Statistics & Valuation Metrics
Total Valuation
Zhaoke Ophthalmology Ltd. has a market cap or net worth of HKD 1.11B. The enterprise value is HKD 515.77M.
- Market Cap
- HKD 1.11B
- Enterprise Value
- HKD 515.77M
Share Statistics
Zhaoke Ophthalmology Ltd. has 548,839,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 548,839,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Zhaoke Ophthalmology Ltd.’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -14.09%.
- Return on Equity (ROE)
- -0.13
- Return on Assets (ROA)
- -0.11
- Return on Invested Capital (ROIC)
- -14.09%
- Return on Capital Employed (ROCE)
- -0.17
- Revenue Per Employee
- 109.29K
- Profits Per Employee
- -714.29K
- Employee Count
- 285
- Asset Turnover
- 0.02
- Inventory Turnover
- 4.35
Valuation Ratios
The current PE Ratio of Zhaoke Ophthalmology Ltd. is -4.49. Zhaoke Ophthalmology Ltd.’s PEG ratio is -0.17.
- PE Ratio
- -4.49
- PS Ratio
- 26.95
- PB Ratio
- 0.67
- Price to FCF
- -5.30
- Price to Operating Cash Flow
- -5.42
- PEG Ratio
- -0.17
Income Statement
In the last 12 months, Zhaoke Ophthalmology Ltd. had revenue of 31.15M and earned -203.57M in profits. Earnings per share was -0.37.
- Revenue
- 31.15M
- Gross Profit
- -32.57M
- Operating Income
- -266.41M
- Pretax Income
- -203.57M
- Net Income
- -203.57M
- EBITDA
- -214.09M
- Earnings Per Share (EPS)
- -0.37
Cash Flow
In the last 12 months, operating cash flow was -172.56M and capital expenditures -4.22M, giving a free cash flow of -176.78M billion.
- Operating Cash Flow
- -172.56M
- Free Cash Flow
- -176.78M
- Free Cash Flow per Share
- -0.32
Dividends & Yields
Zhaoke Ophthalmology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -18.88%
- Earnings Yield
- -22.82%
Stock Price Statistics
- Beta
- 1.85
- 52-Week Price Change
- -34.79%
- 50-Day Moving Average
- 2.37
- 200-Day Moving Average
- 2.77
- Relative Strength Index (RSI)
- 37.13
- Average Volume (3m)
- 183.94K
Important Dates
Zhaoke Ophthalmology Ltd. upcoming earnings date is Mar 29, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Mar 29, 2027
- Ex-Dividend Date
- ―
Financial Position
Zhaoke Ophthalmology Ltd. as a current ratio of 4.18, with Debt / Equity ratio of 18.55%
- Current Ratio
- 4.18
- Quick Ratio
- 4.14
- Debt to Market Cap
- 0.19
- Net Debt to EBITDA
- 4.69
- Interest Coverage Ratio
- -30.11
Taxes
In the past 12 months, Zhaoke Ophthalmology Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Zhaoke Ophthalmology Ltd. EV to EBITDA ratio is -1.89, with an EV/FCF ratio of -2.32.
- EV to Sales
- 11.80
- EV to EBITDA
- -1.89
- EV to Free Cash Flow
- -2.32
- EV to Operating Cash Flow
- -2.38
Balance Sheet
Zhaoke Ophthalmology Ltd. has HKD 1.01B in cash and marketable securities with HKD 266.51M in debt, giving a net cash position of HKD 744.77M billion.
- Cash & Marketable Securities
- HKD 1.01B
- Total Debt
- HKD 266.51M
- Net Cash
- HKD 744.77M
- Net Cash Per Share
- HKD 1.36
- Tangible Book Value Per Share
- HKD 1.66
Margins
Gross margin is -101.92%, with operating margin of -768.98%, and net profit margin of -614.52%.
- Gross Margin
- -101.92%
- Operating Margin
- -768.98%
- Pretax Margin
- -614.52%
- Net Profit Margin
- -614.52%
- EBITDA Margin
- -623.02%
- EBIT Margin
- -768.98%
Analyst Forecast
The average price target for Zhaoke Ophthalmology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.56%
- EPS Growth Forecast
- 20.20%
Scores
- Smart Score
- 4
- AI Score
- 46